Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer
Chinese Journal of Lung Cancer, 2015 Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG +4 more
doaj +1 more source
Clinics, 2014 OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang +2 more
doaj +1 more source
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer [PDF]
, 2004 Background Advanced ovarian cancer is the leading non-breast gynaecologic cause of malignant pleural effusion. Aim of this study was to assess the efficacy of mitoxantrone sclerotherapy as a palliative treatment of malignant pleural effusions due to ...
FH Hausheer +26 more
core +2 more sources
Case Reports in Oncology, 2021 Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino +8 more
doaj +1 more source
Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis [PDF]
, 2014 INTRODUCTION: Malignant pleural effusion can complicate most cancers. It causes breathlessness and requires hospitalisation for invasive pleural drainages. Malignant effusions often herald advanced cancers and limited prognosis.
Bint, M +15 more
core +1 more source
Lumican is overexpressed in lung adenocarcinoma pleural effusions. [PDF]
, 2015 Adenocarcinoma (AdC) is the most common lung cancer subtype and is often associated with pleural effusion (PE). Its poor prognosis is attributable to diagnostic delay and lack of effective treatments and there is a pressing need in discovering new ...
Arrigoni, Giorgio +9 more
core +9 more sources
Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project [PDF]
, 2017 Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection ...
Bintcliffe, Oliver +10 more
core +1 more source
Chinese Medical Journal, 2015 Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu +10 more
doaj +1 more source
Malignant Pleural Effusion and Its Current Management: A Review
Medicina, 2019 Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a common symptom and accompanying manifestation of metastatic disease.
Kristijan Skok +3 more
semanticscholar +1 more source
Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis [PDF]
, 2012 Rationale: Talc is very effective for pleurodesis, but there is concern about complications, especially acute respiratory distress syndrome. Objectives: It was the aim of this study to investigate if talc with a high concentration of small particles ...
Arellano Orden, Elena +5 more
core +1 more source